GlassScriptPhysician profile
Jack C Burns
NPI 1922413889
$7,101.71
in general payments reported to CMS, 2019-2025
21 companies · $1,360 in 2025
The $1,360 reported for 2025 was more than what 77% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $563 · 2021: $499 · 2022: $1,665 · 2023: $1,169 · 2024: $1,692 · 2025: $1,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,819 · Long Term Medical Supply Or Device Loan: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,819.38 |
| Long Term Medical Supply Or Device Loan | $401.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,463.70 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Micromatrix |
| Kerecis Limited | $1,198.84 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Ethicon US, LLC | $799.23 | 2022-2025 | Vistaseal, Monocryl, Echelon; Endopath |
| Sientra, INC. | $786.80 | 2021-2022 | |
| Mentor Worldwide LLC | $691.27 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Checkpoint Surgical, INC | $339.25 | 2020-2025 | Checkpoint Stimulators |
| Abbvie INC. | $330.46 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Baxter Healthcare | $268.52 | 2020-2024 | Perclot |
| Smith+Nephew, INC. | $255.54 | 2021-2025 | Renasys Go V2 Home, Collagenase Santyl, Pico 7 |
| Organogenesis INC. | $246.97 | 2023-2025 | Puraply, Puraply Wound Matrix |
| Vioptix INC | $190.63 | 2021 | |
| Bone Support INC. | $129.14 | 2024 | Cerament G, Ceramentbone Void Filler |
| Allergan, INC. | $125.00 | 2019 | |
| Solventum Corporation | $87.46 | 2024-2025 | Activ.A.C., Promogran Prisma, Prevena |
| Endo USA, INC. | $42.92 | 2024-2025 | Xiaflex |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifenet Health | $33.53 | 2023 | |
| Polynovo North America LLC | $32.97 | 2023 | |
| Convatec INC. | $22.01 | 2023 | |
| Acera Surgical, INC. | $21.00 | 2025 | Restrata Wound Matrix |
| Kci USA, INC. | $19.60 | 2023 | Prevena Restor Bellaform, V.A.C. Veraflo, Activ.A.C. |
| Endo Pharmaceuticals INC. | $16.87 | 2023 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$11,496.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.